List view / Grid view

News

Sandoz proposed biosimilars recommended for EU approval

25 April 2017 | By Niamh Marriott, Junior Editor

The Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions, separately recommending the approval of both Sandoz's (a Novartis division) biosimilar rituximab and biosimilar etanercept in Europe, to treat the same indications as their respective reference medicines.

BMS Phase II study in non-alcoholic steatohepatitis a success 

24 April 2017 | By Niamh Marriott, Junior Editor

BMS-986036 is a pegylated analogue of human fibroblast growth factor 21, a key regulator of metabolism. In preclinical models of non-alcoholic steatohepatitis (NASH), BMS-986036 improved steatosis, inflammation, hepatocyte ballooning, and fibrosis.

Rainin TerraRack™ benefits cell differentiation studies

21 April 2017 | By METTLER TOLEDO

METTLER TOLEDO’s Rainin TerraRack™ pipette tip racks are proving advantageous for the University of Glasgow’s Centre for Cell Engineering, where scientists are investigating cell differentiation and behavior on a variety of materials...